| Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
|---|---|---|---|---|---|---|---|---|---|---|
| 14 Jun 24 | LYEL Lyell Immunopharma | Option Common Stock | Grant | Acquire A | No | No | 2.36 | 130,000 | 306.80 k | 130,000 |
| 23 May 24 | RAPT RAPT Therapeutics | Stock Option Common Stock | Grant | Acquire A | No | No | 4.63 | 36,490 | 168.95 k | 36,490 |
| 5 Apr 24 | NGM Ngm Biopharmaceuticals | Common Stock | Dispose U | Yes | No | 0 | 2,769,168 | 0.00 | 0 | |
| 5 Apr 24 | NGM Ngm Biopharmaceuticals | Common Stock | Dispose U | No | No | 0 | 5,172 | 0.00 | 0 | |
| 5 Apr 24 | NGM Ngm Biopharmaceuticals | Stock Option Common Stock | Sale back to company | Dispose D | No | No | 8.14 | 225,000 | 1.83 mm | 0 |
| 5 Apr 24 | NGM Ngm Biopharmaceuticals | Stock Option Common Stock | Sale back to company | Dispose D | No | No | 12.06 | 50,000 | 603.00 k | 0 |
| 5 Apr 24 | NGM Ngm Biopharmaceuticals | Stock Option Common Stock | Sale back to company | Dispose D | No | No | 16.47 | 75,000 | 1.24 mm | 0 |
| 5 Apr 24 | NGM Ngm Biopharmaceuticals | Stock Option Common Stock | Sale back to company | Dispose D | No | No | 31.93 | 80,000 | 2.55 mm | 0 |
| 5 Apr 24 | NGM Ngm Biopharmaceuticals | Stock Option Common Stock | Sale back to company | Dispose D | No | No | 15.2 | 80,000 | 1.22 mm | 0 |
| 5 Apr 24 | NGM Ngm Biopharmaceuticals | Stock Option Common Stock | Sale back to company | Dispose D | No | No | 3.69 | 78,407 | 289.32 k | 0 |
